Dual MGMT inactivation by promoter hypermethylation and loss of the long arm of chromosome 10 in glioblastoma
Abstract Background Epigenetic inactivation of O6‐methylguanine‐methyltransferase (MGMT) gene by methylation of its promoter is predictive of Temozolomid (TMZ) response in glioblastoma (GBM). MGMT is located on chromosome 10q26 and the loss of chromosome 10q is observed in 70% of GBMs. In this study...
Main Authors: | Sophie Richard, Gaëlle Tachon, Serge Milin, Michel Wager, Lucie Karayan‐Tapon |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-09-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.3217 |
Similar Items
-
Glioblastoma and the significance of MGMT gene methylation
by: Payam Izadpanahi, et al.
Published: (2014-08-01) -
Lomeguatrib Increases the Radiosensitivity of MGMT Unmethylated Human Glioblastoma Multiforme Cell Lines
by: Anna Kirstein, et al.
Published: (2021-06-01) -
Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma
by: Magda Sayed Mahmoud, et al.
Published: (2024-03-01) -
Peritumoral ADC Values Correlate with the MGMT Methylation Status in Patients with Glioblastoma
by: Valentin Karl Ladenhauf, et al.
Published: (2023-02-01) -
A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM]
by: David Gibson, et al.
Published: (2024-03-01)